Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001799256-20-000001
Filing Date
2020-01-09
Accepted
2020-01-09 11:13:40
Documents
1
Effectiveness Date
2020-01-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6568
  Complete submission text file 0001799256-20-000001.txt   7630
Mailing Address 200 US HIGHWAY 9 SUITE 500 MANALAPAN NJ 07726
Business Address 200 US HIGHWAY 9 SUITE 500 MANALAPAN NJ 07726 732-761-8284
Metuchen Pharmaceuticals, LLC (Filer) CIK: 0001799256 (see all company filings)

EIN.: 813546200 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-357536 | Film No.: 20517401